Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC).
Foerster B, Abufaraj M, Mari A, Seisen T, Bandini M, Schweitzer D, Czech AK, Moschini M, D'Andrea D, Bianchi M, Hendricksen K, Rouprêt M, Briganti A, van Rhijn BWG, Chłosta P, Colin P, John H, Shariat SF. Foerster B, et al. Among authors: briganti a. Clin Genitourin Cancer. 2021 Jun;19(3):272.e1-272.e7. doi: 10.1016/j.clgc.2020.09.002. Epub 2020 Sep 18. Clin Genitourin Cancer. 2021. PMID: 33046411
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
Gallina A, Chun FK, Briganti A, Shariat SF, Montorsi F, Salonia A, Erbersdobler A, Rigatti P, Valiquette L, Huland H, Graefen M, Karakiewicz PI. Gallina A, et al. Among authors: briganti a. Eur Urol. 2007 Jul;52(1):98-105. doi: 10.1016/j.eururo.2007.01.060. Epub 2007 Jan 22. Eur Urol. 2007. PMID: 17267098 Clinical Trial.
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Briganti A, Chun FK, Hutterer GC, Gallina A, Shariat SF, Salonia A, Scattoni V, Valiquette L, Montorsi F, Rigatti P, Graefen M, Huland H, Karakiewicz PI. Briganti A, et al. Eur Urol. 2007 Sep;52(3):733-43. doi: 10.1016/j.eururo.2007.02.054. Epub 2007 Mar 6. Eur Urol. 2007. PMID: 17350750
Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.
Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML. Briganti A, et al. Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1. Eur Urol. 2009. PMID: 18838212
1,472 results